Interaction of endogenous ligands mediating antinociception

Brain Research Reviews

Volumn 52, Issue 1, 2006, Pages 69-92

  Horvath, Gyongyi ^a,b   Kekesi, Gabriella ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Behavior; Endogenous; Interaction; Pain; Receptor

Indexed keywords

ADENOSINE; AGMATINE; ANALGESIC AGENT; ANANDAMIDE; ARGININE; BETA ENDORPHIN; CALCITONIN; ENDOMORPHIN 1; ENDOMORPHIN 2; ESTRADIOL; GANGLIOSIDE; KYNURENIC ACID; KYOTORPHIN; LEUCINE ENKEPHALIN; METENKEPHALIN; NEUROTENSIN; NOCICEPTIN; NOCISTATIN; NORADRENALIN; OUABAIN; PALMITYLETHANOLAMIDE; PARATHYROID HORMONE [44-68]; PARATHYROID HORMONE [64-84]; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE[1-34]; PROGESTERONE; SEROTONIN; SPINORPHIN; TUFTSIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIC ACTIVITY; ANTINOCICEPTION; DRUG MECHANISM; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW;

ANALGESICS, OPIOID; ANIMALS; DRUG INTERACTIONS; HUMANS; LIGANDS; MODELS, BIOLOGICAL; NARCOTICS; NEUROTRANSMITTER AGENTS; NOCICEPTORS; OLIGOPEPTIDES; PAIN; PAIN THRESHOLD;

EID: 33745898512     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2006.01.001     Document Type: Review

References (204)

1. Advokat C. Intrathecal coadministration of serotonin and morphine differentially modulates the tail-flick reflex of intact and spinal rats. Pharmacol. Biochem. Behav. 45 (1993) 871-879
2. Akil H., Watson S.J., Young E., Lewis M.E., Khachaturian H., and Walker J.M. Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7 (1984) 223-255
3. Appadu B.L., and Lambert D.G. Interaction of i.v. anaesthetic agents with 5-HT3 receptors. Br. J. Anaesth. 76 (1996) 271-273
4. Aran S., and Proudfit H.K. Antinociception produced by interactions between intrathecally administered adenosine agonists and norepinephrine. Brain Res. 513 (1990) 255-263
5. Aran S., and Proudfit H.K. Antinociceptive interactions between intrathecally administered α2 noradrenergic agonist and 5′-N-ethylcarboxamide adenosine. Brain Res. 519 (1990) 287-293
6. Aricioglu-Kartal F., and Uzbay T. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci. 61 (1997) 1775-1781
7. Arima T., Kitamura Y., Nishiya T., Takagi H., and Nomura Y. Kyotorphin (l-tyrosyl-l-arginine) as a possible substrate for inducible nitric oxide synthase in rat glial cells. Neurosci. Lett. 212 (1996) 1-4
8. G-nitro-l-arginine binding to neuronal nitric oxide synthase in rat brain. Neurochem. Int. 30 (1997) 605-611
9. Auguet M., Viossat I., Marin J.-G., and Chabrier P.-E. Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn. J. Pharmacol. 69 (1995) 285-287
10. Bach F.W. β-endorphin in the brain. A role in nociception. Acta Anaesthesiol. Scand. 41 (1997) 133-140
11. Baker A.K., Hoffmann V.L., and Meert T.F. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay. Acta Anaesthesiol. Belg. 53 (2002) 203-212
12. Bardin L., Bardin M., Lavarenne J., and Eschalier A. Effect of intrathecal serotonin on nociception in rats: influence of the pain test used. Exp. Brain Res. 113 (1997) 81-87
13. Bardin L., Schmidt J., Alloui A., and Eschalier A. Effect of intrathecal administration of serotonin in chronic pain models in rats. Eur. J. Pharmacol. 409 (2000) 37-43
14. Bartok R.E., and Craft R.M. Sex differences in opioid antinociception. J. Pharmacol. Exp. Ther. 282 (1997) 769-778
15. Behbehani M.M., and Pert A. A mechanism for the analgesic effect of neurotensin as revealed by behavioral and electrophysiological techniques. Brain Res. 324 (1984) 35-42
16. Belfrage M., Segerdahl M., Arnér S., and Sollevi A. The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain. Anesth. Analg. 89 (1999) 136-142
17. Bell R.F., Eccleston C., and Kalso E. Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review. J. Pain Symptom Manage 26 (2003) 867-875
18. Boom A., Mollereau C., Meunier J.C., Vassart G., Parmentier M., Vanderhaeghen J.-J., and Schiffmann S.N. Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system. Neuroscience 91 (1999) 991-1007
19. Bridges R.S., and Ronsheim P.M. Immunoreactive beta-endorphin concentrations in brain and plasma during pregnancy in rats-Possible modulation by progesterone and estradiol. Neuroendocrinology 45 (1987) 381-388
20. Calcutt C.R., Doggett N.S., and Spencer P.S.J. Modification of the anti-nociceptive activity of morphine by centrally administered ouabain and dopamine. Psychopharmacologia 21 (1971) 111-117
21. Calignano A., La Rana G., Giuffrida A., and Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 394 (1998) 277-281
22. Calignano A., La Rana G., and Piomelli D. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur. J. Pharmacol. 419 (2001) 191-198
23. Calo G., Guerrini R., Rizzi A., Salvadori S., and Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129 (2000) 1261-1283
24. Carpenedo R., Pittaluga A., Cozzi A., Attucci S., Galli A., Raiteri M., and Moroni F. Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur. J. Neurosci. 13 (2001) 2141-2147
25. Chiari A., and Eisenach J.C. Intrathecal adenosine: interactions with spinal clonidine and neostigmine in rat models of acute nociception and postoperative hypersensitivity. Anesthesiology 90 (1999) 1413-1421
26. Chiari A., Yaksh T.L., Myers R.R., Provencher J., Moore L., Lee C.-S., and Eisenach J.C. Preclinical toxicity screening of intrathecal adenosine in rats and dogs. Anesthesiology 91 (1999) 824-832
27. Coggeshall R.E., and Carlton S.M. Receptor localization in the mammalian dorsal horn and primary afferent neurons. Brain Res. Rev. 24 (1997) 28-66
28. 154-181 effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro. Br. J. Pharmacol. 128 (1999) 1779-1787
29. Crain S.M., and Shen K.-F. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res. 575 (1992) 13-24
30. Crain S.M., and Shen K.-F. Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor function. Brain Res. 856 (2000) 227-235
31. Csullog E., Joo G., Toth G., Dobos I., Benedek G., and Horvath G. Antinociceptive effect of continuous intrathecal administration of endomorphin-1. Pain 94 (2001) 31-38
32. Cuello A.C., Priestley J.V., and Paxinos G. Substance P and enkephalin containing pathways. In: Paxinos G. (Ed). The Rat Nervous System (1985), Academic Press, Australia 441-469
33. Dawson-Basoa M.B., and Gintzler A.R. 17-β-Estradiol and progesterone modulate an intrinsic opioid analgesic system. Brain Res. 601 (1993) 241-245
34. Dawson-Basoa M.E., and Gintzler A.R. Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms. Pain 64 (1996) 608-615
35. Dawson-Basoa M., and Gintzler A.R. Involvement of spinal cord δ opiate receptors in the antinociception of gestation and its hormonal simulation. Brain Res. 757 (1997) 37-42
36. Dawson-Basoa M., and Gintzler A.R. Gestational and ovarian sex steroid antinociception: synergy between spinal κ and δ opioid systems. Brain Res. 794 (1998) 61-67
37. DeLander G.E., and Hopkins C.J. Interdependence of spinal adenosinergic, serotonergic and noradrenergic systems mediating antinociception. Neuropharmacology 26 (1987) 1791-1794
38. DeLander G.E., and Keil G.J. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice. J. Pharmacol. Exp. Ther. 268 (1994) 943-951
39. DeLander G.E., and Wahl J.J. Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally. J. Pharmacol. Exp. Ther. 246 (1988) 565-570
40. Desmeules J., Rollason V., Piguet V., and Dayer P. Clinical pharmacology and rationale of analgesic combinations. Eur. J. Anaesthesiol. 20 S28 (2003) 7-12
41. Di Marzo V., Melck D., Bisogno T., and De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21 (1998) 521-528
42. Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.K., Zimmer A.M., Zimmer A., and Martin B.R. Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice. Evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 75 (2000) 2434-2444
43. Drolet G., Van Bockstaele E.J., and Aston-Jones G. Robust enkephalin innervation of the locus coeruleus from the rostral medulla. J. Neurosci. 12 (1992) 3162-3174
44. Dubuc I., Sarret P., Labbe-Jullie C., Botto J.M., Honore E., Bourdel E., Martinez J., Costentin J., Vincent J.P., Kitabgi P., and Mazella J. Identification of the receptor subtype involved in the analgesic effect of neurotensin. J. Neurosci. 19 (1999) 503-510
45. Eisenach J.C., Hood D.D., and Curry R. Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology 96 (2002) 29-34
46. Ellington H.C., Cotter M.A., Cameron N.A., and Ross R.A. The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats. Neuropharmacology 42 (2002) 966-975
47. Faber E.S.L., Chamber J.P., and Evans R.H. Depression of NMDA receptor-mediated synaptic transmission by four α2 adrenoceptor agonists on the in vitro rat spinal cord preparation. Br. J. Pharmacol. 124 (1998) 507-512
48. Fields H.L., Heinricher M.M., and Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 14 (1991) 219-245
49. Firbanks C.A., Schreiber K.L., Brewer K.L., Yu C.-G., Stone L.S., Kitto K.F., Nguyen H.O., Grocholski B.M., Shoeman D.W., Kehl L.J., Regunathan S., Reis D.J., Yezierski R.P., and Wilcox G.L. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10584-10589
50. Fromm C., DeLeo J., Coombs D.W., Colburn R.W., and Twitchell B.B. The ganglioside GM1 decrease autotomy but not substance P depletion in a peripheral mononeuropathy rat model. Anesth. Analg. 77 (1993) 501-506
51. Furst S. Transmitter involved in antinociception in the spinal cord. Brain Res. Bull. 48 (1999) 129-141
52. Ganong A.H., Lanthorn T.H., and Cotman C.W. Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res. 273 (1983) 170-174
53. Gibson D.A., Harris B.R., Rogers D.T., and Littleton J.M. Radioligand binding studies reveal agmatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil. Brain Res. 952 (2002) 71-77
54. Goettl V.M., Lindsey A.E., Neff N.H., and Hadjiconstantinou M. GM1 ganglioside restores abnormal responses to acute thermal and mechanical stimuli in aged rats. Brain Res. 858 (2000) 380-385
55. Gomes J.A., Li X., Pan H.-L., and Eisenach J.C. Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats. Anesthesiology 91 (1999) 1072-1079
56. Gui X., Carraway R.E., and Dobner P.R. Endogenous neurotensin facilitates visceral nociception and is required for stress-induced antinociception in mice and rats. Neuroscience 126 (2004) 1023-1032
57. Hager H.A., Marhofer P., Sitzwohl C., Adler L., Kettner S., and Semsroth M. Caudal clonidine prolongs analgesia from caudal S(+)-ketamine in children. Anesth. Analg. 94 5 (2002) 1169-1172
58. Hajós M., and Engberg G. Kynurenic acid blocks chemogenic nociception. J. Pharm. Pharmacol. 42 (1990) 373-374
59. Harvey S., and Hayer S. Parathyroid hormone binding sites in the brain. Peptides 14 (1993) 1187-1191
60. Hayes R.L., Mao J., Price D.D., Germano A., d'Avella D., Fiori M., and Mayer D.J. Pretreatment with gangliosides reduces abnormal nociceptive responses associated with a rodent peripheral neuropathy. Pain 48 (1992) 391-396
61. Heinricher M.M., and McGaraughty S. Analysis of excitatory amino acid transmission within the rostral ventromedial medulla: implications for circuitry. Pain 75 (1998) 247-255
62. Heinricher M.M., McGaraughty S., and Farr D.A. The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine. Pain 81 (1999) 57-65
63. Herman Z.S., Jez W., Siemion I.Z., and Nawrocka E. Interaction on the antinociceptive effect between neurotensin and enkephalins or tuftsin. Acta Physiol. Pol. 35 (1984) 5-6
64. Heyliger S.O., Goodman C.B., Ngong J.M., and Soliman K.F.A. The analgesic effects of tryptophan and its metabolites in the rat. Pharmacol. Res. 38 (1998) 243-244
65. Hilmas C., Pereira E.F., Alkondon M., Rassoulpour A., Schwarcz R., and Albuquerque E.X. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 12 (2001) 7463-7473
66. Hohmann A.G. Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives. Chem. Phys. Lipids 121 (2002) 173-190
67. Honda M., Okutsu H., Matsuura T., Miyagi T., Yamamoto Y., Hazato T., and Ono H. Spinorphin, and endogenous inhibitor of enkephalin-degrading enzymes, potentiates Leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice. Jpn. J. Pharmacol. 87 (2001) 261-267
68. Horan P., Tallarida R.J., Haaseth R.C., Matsunaga T.O., Hruby V.J., and Porreca F. Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity. Life Sci. 50 (1992) 1535-1541
69. Horvath G. Endomorphin-1 and endomorphin-2. Pharmacology of the selective endogenous μ-opioid receptor agonists. Pharmacol. Ther. 88 (2000) 437-463
70. Horvath G., Klimscha W., Dobos I., Szikszay M., Benedek G., and Eisenach J.C. Intrathecal agmatine pretreatment decreases the hyperalgesia and potentiates the morphine induced antinociception in rats. Reg. Anesth. Pain Med. 9 (1997) 67
71. Horvath G., Kekesi G., Dobos I., Szikszay M., Klimscha W., and Benedek G. Effect of intrathecal agmatine on inflammation-induced thermal hyperalgesia in rats. Eur. J. Pharmacol. 368 (1999) 197-204
72. Horvath G., Szikszay M., Tomboly C., and Benedek G. Antinociceptive effects of intrathecal endomorphin-1 and -2 in rats. Life Sci. 65 (1999) 2635-2641
73. Horvath G., Joo G., Dobos I., Klimscha W., Toth G., and Benedek G. The synergistic antinociceptive interactions of endomorphin-1 with dexmedetomidine and/or S(+)-ketamine in rats. Anesth. Analg. 93 (2001) 1018-1024
74. +-ATPase using in vitro and in vivo studies. Eur. J. Pharmacol. 458 (2003) 291-297
75. Hou S.-W., Qi J.-S., Zhang Y., and Qiao J.-T. Spinal antinociceptive effect of agmatine and tentative analysis of involved receptors: study in an electrophysiological model of rats. Brain Res. 968 (2003) 277-280
76. Hughes J., Smith T.W., and Kosterlitz H.W. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258 (1975) 577-579
77. s in capsaicin-insensitive nociceptors, respectively. J. Pharmacol. Exp. Ther. 306 (2003) 141-146
78. Jevtovic-Todorovic V., Wozniak D.F., Powell S., Nardi A., and Olney J.W. Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects. Brain Res. 781 (1998) 202-211
79. Joo G., Horvath G., Klimscha W., Kekesi G., Dobos I., Szikszay M., and Benedek G. The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats. Anesthesiology 93 (2000) 231-241
80. Kawabata A., Umeda N., and Takagi H. l-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Br. J. Pharmacol. 109 (1992) 73-79
81. Kawabata A., Fukuzumi Y., Fukushima Y., and Takagi H. Antinociceptive effect of l-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opioidergic systems. Eur. J. Pharmacol. 218 (1992) 153-158
82. Kawabata A., Manabe S., and Takagi H. Comparison of antinociception induced by supraspinally administered l-arginine and kyotorphin. Br. J. Pharmacol. 112 (1994) 817-822
83. G-nitro-l-arginine methyl ester and α-methyl-l-ornithine inhibit kyotorphin synthetase from rat brain. Peptides 16 (1995) 1317-1319
84. Kawabata A., Nishimura Y., and Takagi H. l-leucyl-l-arginine, naltrindole and d-arginine block antinociception elicited by l-arginine in mice with carrageenin-induced hyperalgesia. Eur. J. Pharmacol. 296 (1996) 23-31
85. Kayser V., Berkley K., Keita H., Gautron M., and Guilbaud G. Estrous and sex variations in vocalization thresholds to hindpaw and tail pressure stimulation in the rat. Brain Res. 742 (1996) 352-354
86. Kekesi G., Joo G., Csullog E., Dobos I., Klimscha W., Toth K., Benedek G., and Horvath G. The antinociceptive effect of intrathecal kynurenic acid and its interaction with endomorphin-1 in rats. Eur. J. Pharmacol. 445 (2002) 93-96
87. Kekesi G., Dobos I., Benedek G., and Horvath G. The antinociceptive potencies and interactions of endogenous ligands during continuous intrathecal administration: adenosine, agmatine, and endomorphin-1. Anesth. Analg. 98 2 (2004) 420-426
88. Kekesi G., Joo G., Csullog E., Peter-Szabo M., Benedek G., and Horvath G. Dose-independent antinociceptive interaction of endogenous ligands at the spinal level. Brain Res. 1029 (2004) 93-102
89. Khan I.M., Taylor P., and Yaksh T.L. Stimulatory pathways and sites of action of intrathecally administered nicotinic agents. J. Pharmacol. Exp. Ther. 271 (1994) 1550-1557
90. Kitabgi P. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes. Curr. Opin. Drug Discov. Dev. 5 (2002) 764-776
91. Kolesnikov Y., Jain S., and Pasternak G.W. Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol. 296 (1996) 17-22
92. Labuz D., Przewlocki R., and Przewlocka B. Cross-tolerance between the different μ-opioid receptor agonists endomorphin-1, endomorphin-2 and morphine at the spinal level in the rat. Neurosci. Lett. 334 2 (2002) 127-130
93. Lavand'homme P., and Eisenach J.C. Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain. Pain 80 (1999) 31-36
94. Lee Y.-W., and Yaksh T.L. Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model. Anesthesiology 82 (1995) 741-748
95. Lee N.M., Leybin L., Chang J.K., and Loh H.H. Opiate and peptide interaction: effect of enkephalins on morphine analgesia. Eur. J. Pharmacol. 68 (1980) 181-185
96. Lee T.-L., Fung F.M.Y., Chen F.-G., Chou N., Okuda-Ashitaka E., Ito S., Nishiuchi Y., Kimura T., and Tachibana S. Identification of human, rat and mouse nocistatin in brain and human cerebrospinal fluid. NeuroReport 10 (1999) 1537-1541
97. Li X., and Eisenach J.C. α2A-Adrenoceptor stimulation reduces capsaicin-induced glutamate release from spinal cord synaptosomes. J. Pharmacol. Exp. Ther. 299 (2001) 939-944
98. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., and Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263 (1994) 966-969
99. Loring R.H. Agmatine acts as an antagonist of neuronal nicotinic receptors. Br. J. Pharmacol. 99 (1990) 207-211
100. Maldonado R., Valverde O., Turcaud S., Fournié-Zaluski M.-C., and Roques B.P. Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation. Pain 58 (1994) 77-83
101. Malmberg A.B., Yaksh T.L., and Calcutte N.A. Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats. Neurosci. Lett. 161 (1993) 45-48
102. Mao J., Price D.D., Hayes R.L., and Mayer D.J. Intrathecal GM1 ganglioside and local nerve anesthesia reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res. 584 (1992) 28-35
103. Marek P., Ben-Eliyahu S., Gold M., and Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 574 (1991) 77-81
104. Martin B.R., Mechoulam R., and Razdan R.K. Discovery and characterization of endogenous cannabinoids. Life Sci. 65 (1999) 573-595
105. Martin-Schild S., Gerall A.A., Kastin A.J., and Zadina J.E. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J. Comp. Neurol. 405 (1999) 450-471
106. +-ATPase in morphine-induced antinociception. J. Pharmacol. Exp. Ther. 306 (2003) 1122-1128
107. Miaskowski C., Taiwo Y.O., and Lavine J.D. K- and σ-opioid agonists synergize to produce potent analgesia. Brain Res. 509 (1990) 165-168
108. Millan M.J. Descending control of pain. Prog. Neurobiol. 66 (2002) 355-474
109. 2-opioid receptors in the spinal cord are involved in the cold water swimming-induced antinociception in the mouse. Life Sci. 61 (1997) PL81-PL86
110. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53 (2001) 381-415
111. Moroni F., Russi P., Lombardi G., Beni M., and Carla V. Presence of kynurenic acid in the mammalian brain. J. Neurochem. 51 (1988) 177-180
112. Nagaoka H., Sakurada S., Sakurada T., Takeda S., Nakagawa Y., Kisara K., and Arai Y. Theophylline-induced nociceptive behavioral response in mice: possible indirect interaction with spinal N-methyl-d-aspartate receptors. Neurochem. Int. 22 (1993) 69-74
113. Najjar V.A., and Nishioka K. "Tuftsin": a natural phagocytosis stimulating peptide. Nature 228 (1970) 672-673
114. Nakano H., Minami T., Abe K., Arai T., Tokumura M., Ibii N., Okuda-Ashitaka E., Mori H., and Ito S. Effect of intrathecal nocistatin on the formalin-induced pain in mice versus that of nociceptin/orphanin FQ. J. Pharmacol. Exp. Ther. 292 (2000) 331-336
115. Nemeroff C.B., Osbahr A.J., Manberg P.J., Ervin G.N., and Prange A.J. Alterations in nociception and body temperature after intracisternal administration of neurotensin, β-endorphin, other endogenous peptides, and morphine. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 5368-5371
116. Nikbakht M.-R., and Stone T.W. Suppression of presynaptic responses to adenosine by activation of NMDA receptors. Eur. J. Pharmacol. 427 (2001) 13-25
117. Nishimura K., and Hazato T. Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord. Biochem. Biophys. Res. Commun. 194 (1993) 713-719
118. Nishiyama T., Gyermek L., Lee C., Kawasaki-Yatsugi S., Yamaguchi T., and Hanaoka K. The analgesic interaction between intrathecal clonidine and glutamate receptor antagonists on thermal and formalin-induced pain in rats. Anesth. Analg. 92 3 (2001) 725-732
119. Ochi T., Motoyama Y., and Goto T. The spinal antinociceptive effect of FR140423 is mediated through kyotorphine receptors. Life Sci. 66 (2000) 2239-2245
120. Okuda-Ashitaka E., and Ito S. Nocistatin: a novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor. Peptides 21 (2000) 1101-1109
121. Okuda-Ashitaka E., Minami T., Tachibana S., Yoshihara Y., Nishiuchi Y., Kimura T., and Ito S. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature 392 (1998) 286-289
122. Olgiati V.R., Guidobono F., Netti C., and Pecile A. Localization of calcitonin binding sites in rat central nervous system: evidence of its neuroactivity. Brain Res. 265 (1983) 209-215
123. Osbahr A.J., Nemeroff C.B., Luttinger D., Mason G.A., and Prange A.J. Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone. J. Pharmacol. Exp. Ther. 217 (1981) 645-651
124. Paalzow G.H.M. Noradrenaline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophylline in awake rats. Eur. J. Pharmacol. 252 (1994) 87-97
125. Panocka I., Sadowski B., and Marek P. Adrenalectomy and dexamethasone differentially affect postswim antinociception in mice selectively bred for high and low stress-induced analgesia. Physiol. Behav. 40 (1987) 597-601
126. Pawlak D., Takada Y., Urano T., and Takada A. Serotonergic and kynurenic pathways in rats exposed to foot shock. Brain Res. Bull. 52 (2000) 197-205
127. Pertwee R.G. Cannabinoid receptors and pain. Prog. Neurobiol. 63 (2001) 569-611
128. Pettibone D.J., Hess J.F., Hey P.J., Jacobson M.A., Leviten M., Lis E.V., Mallorga P.J., Pascarella D.M., Snyder M.A., Williams J.B., and Zeng Z. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. J. Pharmacol. Exp. Ther. 300 (2002) 305-313
129. 2-adrenoceptors, N-S. Arch. Pharmacol. 351 (1995) 10-16
130. Poon A., and Sawynok J. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 74 (1998) 235-245
131. 2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J. Neurochem. 88 (2004) 1151-1158
132. 2 cannabinoid receptors. Anesthesiology 99 (2003) 955-960
133. Raasch W., Regunathan S., Li G., and Reeis D.J. Agmatine is widely and unequally distributed in rat organs. Ann. N. Y. Acad. Sci. 763 (1995) 330-334
134. Raigorodsky G., and Urca G. Spinal antinociceptive effects of excitatory amino acid antagonists: quisqualat modulates the action of N-methyl-d-aspartate. Eur. J. Pharmacol. 182 (1990) 37-47
135. Rane K., Segerdahl M., Goiny M., and Sollevi A. Intrathecal adenosine administration. A phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain. Anesthesiology 89 (1998) 1108-1115
136. Rane K., Karlstein R., Sollevi A., Gordh T., and Svensson B.A. Spinal cord morphology after chronic intrathecal administration of adenosine in the rat. Acta Anaesthesiol. Scand. 43 (1999) 1035-1040
137. Rane K., Sollevi A., and Segerdahl M. Intrathecal adenosine administration in abdominal hysterectomy lacks analgesic effect. Acta Anaesthesiol. Scand. 44 (2000) 868-872
138. Reimann W., Schlütz H., and Selve N. The antinociceptive effects of morphine, desipramine, and serotonin and their combinations after intrathecal injection in the rat. Anesth. Analg. 88 (1999) 141-145
139. Reinscheid R.K., Nothacker H.-P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma Jr. F.J., and Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270 (1995) 792-794
140. Reinscheid R.K., Nothacker H.-P., and Civelli O. The orphanin FQ/nociceptin gene: structure, tissue distribution of expression and functional implications obtained from knockout mice. Peptides 21 (2000) 901-906
141. Reis D.J., and Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol. Sci. 21 (2000) 187-193
142. Romano G.J., Mobbs C.V., Howells R.D., and Pfaff D.W. Estrogen regulation of proenkephalin gene-expression in the ventromedial hypothalamus of the rat-temporal qualities and synergism with progesterone. Mol. Brain Res. 5 (1989) 51-58
143. Rothman R.B., and Westfall T.C. Allosteric coupling between morphine and enkephalin receptors in vitro. Mol. Pharmacol. 21 (1982) 548-557
144. Sakurada S., Hayashi T., Yuhki M., Fujimura T., Murayama K., Yonezawa A., Sakurada C., Takeshita M., Zadina J.E., Kastin A.J., and Sakurada T. Differential antagonism of endomorphin-1 and endomorphin-2 spinal nociception by naloxonazine and 3-methoxynaltraxone. Brain Res. 881 (2000) 1-8
145. Sandkühler J. The organization and function of endogenous antinociceptive system. Prog. Neurobiol. 50 (1996) 49-81
146. Sandner-Kiesling A., Li X., and Eisenach J.C. Morphine-induced spinal release of adenosine is reduced in neuropathic rats. Anesthesiology 95 (2001) 1455-1459
147. Sawynok J. Adenosine receptor activation and nociception. Eur. J. Pharmacol. 347 (1998) 1-11
148. Sawynok J., and Reid A. Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception. Behav. Brain Res. 73 (1995) 63-68
149. Sawynok J., Sweeney M.I., and White T.D. Adenosine release may mediate spinal analgesia by morphine. Trends Pharmacol. Sci. 10 (1989) 186-189
150. Schmidt C., Peyroux J., Noble F., Fournié-Zaluski M.-C., and Roques B.P. Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests. Eur. J. Pharmacol. 192 (1991) 253-262
151. Schwarcz R., and Pellicciari R. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J. Pharmacol. Exp. Ther. 303 (2002) 1-10
152. Segerdahl M., Ekblom A., and Sollevi A. The influence of adenosine, ketamine, and morphine on experimentally induced ischemic pain in healthy volunteers. Anesth. Analg. 79 (1994) 787-791
153. Semion I.Z., Nawrocka E., Slon J., Tartar A., Obuchowicz E., Golba K., and Herman Z.S. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs. Pol. J. Pharmacol. Pharm. 42 (1990) 393-401
154. Shiomi H., Kuraishi Y., Ueda H., Harada Y., Amano H., and Takagi H. Mechanism of kyotorphin-induced release of Met-enkephalin from guinea pig striatum and spinal cord. Brain Res. 221 (1981) 161-169
155. Shipley M.T., McLean J.H., and Behbehani M.M. Heterogeneous distribution of neurotensin-like immunoreactive neurons and fibers in the midbrain periaqueductal gray of the rat. J. Neurosci. 7 (1987) 2025-2034
156. 35S]GTPγS binding in rat brain: evidence for partial agonist activity at μ-opioid receptors. J. Neurochem. 70 (1998) 1567-1576
157. Skinner K., Basbaum A.I., and Fields H.L. Cholecystokinin and enkephalin in brain stem pain modulating circuits. NeuroReport 8 (1999) 2995-2998
158. Slart R., Yu A.L., Yaksh T.L., and Sorkin L.S. An animal model of pain produced by systemic administration of an immunotherapeutic anti-ganglioside antibody. Pain 69 (1997) 119-125
159. Sorkin L.S., Yu A.L., Junger H., and Doom C.M. Antibody directed against GD2 produces mechanical allodynia, but not thermal hyperalgesia when administered systemically or intrathecally despite its dependence on capsaicin sensitive afferents. Brain Res. 930 (2002) 67-74
160. Stevenson G.W., Folk J.E., Linsenmayer D.C., Rice K.C., and Negus S.S. Opioid interactions in rhesus monkeys: effects of δ + μ and δ + κ agonists on schedule-controlled responding and thermal nociception. J. Pharmacol. Exp. Ther. 307 (2003) 1054-1064
161. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45 (1993) 309-379
162. Stone T.W. Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection. Trends Pharmacol. Sci. 21 (2000) 149-154
163. Stone T.W. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog. Neurobiol. 64 2 (2001) 185-218
164. Sutters K.A., Miaskowski C., Taiwo Y.O., and Levine J.D. Analgesic synergy and improved motor function produced by combinations of μ-δ- and μ-κ-opioids. Brain Res. 530 (1990) 290-294
165. Sutton L.C., Fleshner M., Mazzeo R., Maier S.F., and Watkins L.R. A permissive role of corticosterone in an opioid form of stress-induced analgesia: blockade of opiate analgesia is not due to stress-induced hormone release. Brain Res. 663 (1994) 19-29
166. Sweeney M.I., White T.D., and Sawynok J. Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline. J. Pharmacol. Exp. Ther. 243 (1987) 657-665
167. Takagi H., Shiomi H., Ueda H., and Amano H. A novel analgesic dipeptide from bovine brain is a possible Met-enkephalin releaser. Nature 282 (1979) 410-412
168. 2-opioid receptors in the brain and spinal cord, respectively. Eur. J. Pharmacol. 242 (1993) 145-150
169. Tallarida R.J. Drug synergism: its detection and applications. J. Pharmacol. Exp. Ther. 298 (2001) 865-872
170. Tallarida R.J., Porreca F., and Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci. 45 (1989) 947-961
171. Terashima M., Hara N., Badruzzaman M., Shimoyama M., and Tsuchiya M. ADP-ribosylation of tuftsin suppresses its receptor-binding capacity and phagocytosis-stimulating activity to murine peritoneal macrophages. FEBS Lett. 412 (1997) 227-232
172. Thorat S.N., and Kulkarni S.K. Effect of MK-801 and its interaction with adenosinergic agents and carbamazepine against hypoxic stress-induced convulsions and death in mice. Methods Find. Exp. Clin. Pharmacol. 12 (1990) 595-600
173. Tseng L.-F., Narita M., Suganuma C., Mizoguchi H., Ohsawa M., Nagase H., and Kampine J.P. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse. J. Pharmacol. Exp. Ther. 292 (2000) 576-583
174. Turski W.A., and Schwarcz R. On the disposition of intrahippocampally injected kynurenic acid in the rat. Exp. Brain Res. 71 (1988) 563-567
175. Turski W.A., Nakamura M., Todd W.P., Carpenter B.K., Whetsell W.O., and Schwarcz R. Identification and quantification of kynurenic acid in human brain tissue. Brain Res. 454 (1988) 164-169
176. Ueda H., Shiomi H., and Takagi H. Regional distribution of a novel analgesic dipeptide kyotorphin (Tyr-Arg) in the rat brain and spinal cord. Brain Res. 198 (1980) 460-464
177. Ueda H., Yoshihara Y., Misawa H., Fukushima N., Katada T., Ui M., Takagi H., and Satoh M. The kyotorphin (tyrosine-arginine) receptor and a selective reconstitution with purified Gi, measured with GTPase and phospholipase C assays. J. Biol. Chem. 264 (1989) 3732-3741
178. Urbanska E.M., Chmielewski M., Kocki T., and Turski W.A. Formation of endogenous glutamatergic receptors antagonist kynurenic acid-Differences between cortical and spinal cord slices. Brain Res. 878 (2000) 210-212
179. Vaccarino F., Guidotti A., and Costa E. Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 8707-8711
180. Van Huysse J.W., and Leenen F.H.H. Role of endogenous brain "ouabain" in the sympathoexcitatory and pressor effects of sodium. Clin. Exp. Hypertens. 20 (1998) 657-667
181. Vaught J.L., and Takemori A.E. A further characterization of the differential effects of leucine enkephalin, methionine enkephalin and their analogs on morphine-induced analgesia. J. Pharmacol. Exp. Ther. 211 (1979) 280-283
182. Vécsei L., and Beal M.F. Comparative behavioral and pharmacological studies with centrally administered kynurenine and kynurenic acid in rats. Eur. J. Pharmacol. 196 (1991) 239-246
183. Vincler M., Eisenach J.C., 24 A.D. Plasticity of spinal nicotinic acetylcholine receptors following spinal nerve ligation Neurosci. Res. 48, 139-145.
184. von Heijne M., Hao J.-X., Sollevi A., and Xu X.-J. Intrathecal adenosine does not relieve allodynia-like behavior in spinally injured rats. NeuroReport 10 (1999) 3247-3251
185. 3H] noradrenaline release in rabbit brain cortex slices. Br. J. Pharmacol. 110 (1993) 1544-1550
186. Vorwerk C.K., Bonheur J., Kreutz M.R., Dreyer E.B., and Laev H. GM1 ganglioside administration protects spinal neurons after glutamate excitotoxicity. Restor. Neurol. Neurosci. 14 (1999) 47-51
187. Walker J.M., Krey J.F., Chu C.J., and Huang S.M. Endocannabinoids and related fatty acid derivates in pain modulation. Chem. Phys. Lipids 121 (2002) 159-172
188. Wang C., Zhao M., Yang J., and Peng S. Synthesis and analgesic effects of kyotorphin-steroid linkers. Steroids 66 (2001) 811-815
189. Welch S.P., and Dewey W.L. The activity of several peptide fragments of parathyroid hormone, alone and in combination with salmon calcitonin and morphine, in antinociceptive tests in the mouse. J. Pharmacol. Exp. Ther. 252 (1990) 140-146
190. Welch S.P., Cooper C.W., and Dewey W.L. Antinociceptive activity of salmon calcitonin injected intraventricularly in mice: modulation of morphine antinociception. J. Pharmacol. Exp. Ther. 237 (1986) 54-58
191. Wiesenfeld-Hallin Z. Combined opioid-NMDA antagonist therapies. Drugs 55 (1999) 1-4
192. Wu G.Y., and Morris S.M. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336 (1998) 1-17
193. Wu H.-E., Hung K.-C., Mizoguchi H., Fujimoto J.M., and Tseng L.F. Acute antinociceptive tolerance and asymmetric cross-tolerance between endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse. J. Pharmacol. Exp. Ther. 299 (2001) 1120-1125
194. Xu J.Y., and Tseng L.F. Increase of nitric oxide by l-arginine potentiates β-endorphin- but not μ-, δ- or k-opioid agonist-induced antinociception in the mouse. Eur. J. Pharmacol. 236 (1993) 137-142
195. Yaksh T.L. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 37 (1989) 111-123
196. Yamamoto T., and Sakashita Y. Effect of nocistatin and its interaction with nociceptin/orphanin FQ on the rat formalin test. Neurosci. Lett. 262 (1999) 179-182
197. Yamamoto T., and Yaksh T.L. Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain 49 (1992) 121-128
198. Yamamoto Y., Ono H., Ueda A., Shimamura M., Nishimura K., and Hazato T. Spinorphin as an endogenous inhibitor of enkephalin-degrading enzymes: roles in pain and inflammation. Curr. Protein Pept. Sci. 3 (2002) 587-599
199. Yang X.-C., and Reis D.J. Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J. Pharmacol. Exp. Ther. 288 (1999) 544-549
200. Yoon M.H., Choi J.I., Park H.C., Bae H.B., Jeong S.W., and Jeong C.Y. Analysis of interactions between serotonin and gabapentin or adenosine in the spinal cord of rats. Pharmacology 74 (2005) 15-22
201. Zadina J.E., Hackler L., Ge L.-J., and Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386 (1997) 499-502
202. Zeller C.B., and Marchase R.B. Gangliosides as modulators of cell function. Am. J. Physiol. 262 (1992) C1341-C1355
203. + pump inhibitor ouabain and its interaction with morphine and lidocain in rats. Anesthesiology 90 (1999) 500-508
204. Zhang Y.-Q., G.-Ji C., Wu G.-C., and Zhao Z.-Q. Kynurenic acid enhances electroacupuncture analgesia in normal and carrageenan-injected rats. Brain Res. 966 (2003) 300-307